Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)

NCT00413023 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

348

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: GW679769

Sponsor

GlaxoSmithKline